0001728117-23-000164.txt : 20231205 0001728117-23-000164.hdr.sgml : 20231205 20231205171224 ACCESSION NUMBER: 0001728117-23-000164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231204 FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Robert Paul JR CENTRAL INDEX KEY: 0002003059 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38796 FILM NUMBER: 231467530 MAIL ADDRESS: STREET 1: C/O GOSSAMER BIO, INC. STREET 2: 3013 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gossamer Bio, Inc. CENTRAL INDEX KEY: 0001728117 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475461709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 922-0718 MAIL ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wk-form4_1701814328.xml FORM 4 X0508 4 2023-12-04 0 0001728117 Gossamer Bio, Inc. GOSS 0002003059 Smith Robert Paul JR 3013 SCIENCE PARK ROAD SAN DIEGO CA 92121 0 1 0 0 Chief Commercial Officer 0 Stock Option (Right to Buy) 0.969 2023-12-04 4 A 0 1500000 0 A 2033-12-03 Common Stock 1500000 1500000 D 25% of the total number of shares subject to the option will vest on December 4, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. /s/ Jeff Boerneke, Attorney-in-Fact 2023-12-05